164 related articles for article (PubMed ID: 9025141)
1. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.
Hunter P
Rev Sci Tech; 1996 Sep; 15(3):913-22. PubMed ID: 9025141
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes.
Cloete M; Dungu B; Van Staden LI; Ismail-Cassim N; Vosloo W
Onderstepoort J Vet Res; 2008 Mar; 75(1):17-31. PubMed ID: 18575060
[TBL] [Abstract][Full Text] [Related]
3. Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.
Patil PK; Bayry J; Ramakrishna C; Hugar B; Misra LD; Prabhudas K; Natarajan C
J Clin Microbiol; 2002 Nov; 40(11):4367-71. PubMed ID: 12409434
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the potency for cattle of trivalent FMD vaccines adjuvanted by aluminum hydroxide-saponin or oil emulsion.
Barei S; Panina GF; Orfei Z; Nardelli L; Castelli S
Zentralbl Veterinarmed B; 1979 Aug; 26(6):454-60. PubMed ID: 232342
[No Abstract] [Full Text] [Related]
5. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
McKercher PD; Graves JH
Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
[TBL] [Abstract][Full Text] [Related]
6. Immune responses of goats against foot-and-mouth disease quadrivalent vaccine: comparison of double oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity.
Patil PK; Bayry J; Ramakrishna C; Hugar B; Misra LD; Natarajan C
Vaccine; 2002 Jun; 20(21-22):2781-9. PubMed ID: 12034105
[TBL] [Abstract][Full Text] [Related]
7. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
Nair SP; Sen AK
Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
[TBL] [Abstract][Full Text] [Related]
8. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep.
Madhanmohan M; Nagendrakumar SB; Kumar R; Anilkumar J; Manikumar K; Yuvaraj S; Srinivasan VA
Res Vet Sci; 2012 Oct; 93(2):1050-9. PubMed ID: 22079173
[TBL] [Abstract][Full Text] [Related]
9. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
Brun A; Chappuis G; Favre H; Roulet C; Terré J
Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
[TBL] [Abstract][Full Text] [Related]
10. Early antibody responses of cattle for foot-and-mouth disease quadrivalent double oil emulsion vaccine.
Patil PK; Bayry J; Nair SP; Gopalakrishna S; Sajjanar CM; Misra LD; Natarajan C
Vet Microbiol; 2002 Jun; 87(2):103-9. PubMed ID: 12034538
[TBL] [Abstract][Full Text] [Related]
11. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
[TBL] [Abstract][Full Text] [Related]
12. Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission.
Cox SJ; Barnett PV; Dani P; Salt JS
Vaccine; 1999 Apr; 17(15-16):1858-68. PubMed ID: 10217583
[TBL] [Abstract][Full Text] [Related]
13. Efficiency testing of foot--and--mouth disease vaccines prepared from strain "C" with different adjuvants.
Sólyom F; Fazekas A; Czelleng F; Makár A; Roith J
Dev Biol Stand; 1976; 35():113-5. PubMed ID: 198276
[TBL] [Abstract][Full Text] [Related]
14. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
Vol'pina OM; Surovoi AYu ; Ivanov VT
Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
[TBL] [Abstract][Full Text] [Related]
16. Compared to Aluminum Hydroxide Adjuvant, Montanide ISA 206 VG Induces a Higher and More Durable Neutralizing Antibody Response against FMDV in Goats.
Taghizadeh M; Azimi SM; Dabaghian M
Arch Razi Inst; 2023 Dec; 78(6):1843-1851. PubMed ID: 38828163
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
[TBL] [Abstract][Full Text] [Related]
18. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
19. Revaccination response of cattle as a function of the 140S foot and mouth disease antigen dose.
Black L; Rweyemamu M; Boge A
J Comp Pathol; 1984 Jul; 94(3):417-24. PubMed ID: 6088598
[TBL] [Abstract][Full Text] [Related]
20. The prospects of oil-adjuvanted foot-and-mouth disease vaccine in South America.
Sutmoller P
Dev Biol Stand; 1976; 35():135-8. PubMed ID: 198279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
